1. science
2. medicine
3. oncology

SELECTED
PHYSICIAN PROFILES
Dedicated to Discovery … Committed to Care
www.dana-farber.org
Table of Contents
About Dana-Farber Cancer Institute
Breast Oncology
Hematologic Oncology
www.dana-farber.org
3
4
6
2
About Dana-Farber Cancer Institute
For more than 60 years, Dana-Farber Cancer Institute has had one goal: to reduce the suffering
caused by cancer through advanced clinical care and cutting-edge scientific research. As a principal
teaching affiliate of Harvard Medical School, we are able to attract many of the best and brightest
physicians in the world to pursue this mission.
At Dana-Farber, we are committed to a multidisciplinary, compassionate, and collaborative model of care
that truly puts patients and their families at the center of all we do. We work in teams organized around
combating specific types of cancer, and patients have easy and direct access to the full range of specialists
they may need.
Our scientific research is focused on understanding the biology of cancer cells in order to develop more
effective therapies that improve patient outcomes. Our lab scientists and clinicians collaborate closely to
quickly translate findings from the lab into therapies that can be delivered to patients in our clinics.
Dana-Farber is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a NCIdesignated Comprehensive Cancer Center. DF/HCC harnesses the expertise and resources of DanaFarber and six other Harvard-affiliated hospitals and research institutions to conduct research focused on
improving the understanding and treatment of cancer. Dana-Farber is also a founding member of the
National Comprehensive Cancer Network, an alliance of the world’s leading cancer centers, working
together to develop cancer treatment guidelines and research that improves the quality and effectiveness
of cancer care. In addition, Dana-Farber has earned “Magnet” status, recognizing the Institute’s highquality patient care, nursing excellence, and innovations in professional nursing practice.
www.dana-farber.org
3
Breast Oncology
The Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber provides comprehensive care for women with all
types of breast cancer, including ductal carcinoma in situ, infiltrating (invasive) ductal carcinoma, lobular carcinoma in situ, infiltrating (invasive)
lobular carcinoma, inflammatory breast cancer, Paget’s disease, and phylloides tumor. We offer specialized expertise for patients with metastatic
breast cancer or breast cancer during pregnancy, as well as an Inflammatory Breast Cancer Program, and the Program for Young Women with Breast
Cancer which addresses the unique needs of women under 40 who are diagnosed with breast cancer. Experts in the Cancer Genetics and Prevention
Program can also create a personalized plan for women at higher risk for developing breast or ovarian cancer.
Patients receive care from a multidisciplinary team of health care professionals with extensive experience and expertise in the unique needs of
women with breast cancer. This includes medical, surgical, and radiation oncologists specializing in breast cancer, as well as radiologists,
pathologists, reproductive medicine specialists, plastic surgeons, oncology nurses, genetic counselors, and more.
Clinical research is a vital aspect of our mission at the Breast Oncology Program. We believe that outstanding clinical care is directly linked to an
active program of clinical research. Physician-researchers take the questions that arise from their experiences in the clinic, answer them through
clinical trials, and take this new knowledge back to the clinic, where it can benefit patients.
At any given time, dozens of research studies involving hundreds of patients are under way within the Breast Oncology Program. These studies are
broad in scope: investigations of prevention and early-detection strategies, new therapies, novel combinations of existing treatments, quality-of-life
studies, and laboratory analyses of tumor samples to better understand the relationship between tumor types and patient outcomes.
Our team is also leading the way in treating breast cancer as a complex family of diseases rather than a single disease. All tumors are assessed for
molecular markers that guide therapy and help determine eligibility for clinical trials exploring innovative new therapies.
New Patient Appointment Phone: 617-632-2175
Fax: 617-632-3715
Leadership - Breast Oncology
J. Dirk Iglehart, MD, Director, Susan F. Smith Center for Women’s Cancers
Eric P. Winer, MD, Director, Breast Oncology Program
Mehra Golshan, MD, FACS, Director, Breast Surgical Services
Jay R. Harris, MD, Chair, Radiation Oncology
Treatment Team
Medical Oncology
Craig A. Bunnell, MD, MPH, MBA
Harold J. Burstein, MD, PhD
Wendy Y. Chen, MD, MPH
Rachel A. Freedman, MD, MPH
Judy E. Garber, MD, MPH
Michael Hassett, MD, MPH
Rinath M. Jeselsohn, MD
Ian E. Krop, MD, PhD
Jennifer A. Ligibel, MD
Nancy U. Lin, MD
Erica L. Mayer, MD, MPH
Susan E. Moody, MD, PhD
Daniel Morganstern, MD
Beth Overmoyer, MD
Leroy M. Parker, MD
Ann H. Partridge, MD, MPH
Rochelle G. Scheib, MD
Lawrence N. Shulman, MD
Daniel P. Silver, MD, PhD
Sara M. Tolaney, MD, MPH
To make an appointment,
call 877-332-4294
Nikhil Wagle, MD
Eric P. Winer, MD
Rachel L. Yung, MD
Pathology
Jane E. Brock, MD, PhD
Deborah A. Dillon, MD
Susan C. Lester, MD, PhD
Andrea L. Richardson, MD, PhD
Radiation Oncology
Jennifer R. Bellon, MD
Jay R. Harris, MD
Susan M. Pierce, MD
Rinaa S. Punglia, MD, MPH
Julia S. Wong, MD
Jack E. Meyer, MD
Annick D. Van den Abbeele, MD
Researcher
Myles A. Brown, MD
Elgene Lim, MD, PhD
Surgical Oncology
Thanh U. Barbie, MD
Katharine Carter, MD
Laura S. Dominici, MD
Margaret M. Duggan, MD, FACS
Mehra Golshan, MD, FACS
J. Dirk Iglehart, MD
Faina Nakhlis, MD
Esther Rhei, MD
Susan L. Troyan, MD
Imaging
Pamela J. DiPiro, MD
Heather Jacene, MD
www.dana-farber.org
4
Breast Oncology - Medical Oncology
Rachel A. Freedman, MD, MPH
Academic Title: Instructor in Medicine, Harvard Medical
School
Discipline: Medical Oncologist
Phone: 617-632-4587
Fellowship: Dana-Farber/Partners CancerCare,
Medical Oncology
Board Certifications: Internal Medicine
Medical Oncology
Fax: 617-632-4587
E-mail: [email protected]
Medical School: Georgetown University School of
Medicine
Residency: Beth Israel Deaconess Medical Center,
Internal Medicine
To make an appointment,
call 877-332-4294
www.dana-farber.org
5
Hematologic Oncology
The Center for Hematologic Oncology provides highly-specialized care for adult patients with all types of blood disorders, including leukemia,
lymphoma, multiple myeloma, and Waldenstrom’s Macroglobulinemia, as well as related blood disorders such as aplastic anemia and myelodysplasia.
Patients receive world-class care from a full array of specialists including hematologic oncologists, radiation oncologists, hematopathologists,
infectious disease specialists, specialized nursing professionals, oncology pharmacists and psychosocial support specialists. This team develops a
personalized treatment plan for each patient, offering the latest therapies and supportive care.
Our Center is dedicated to advancing care through innovative research. We offer more than 100 active therapeutic clinical trials through DanaFarber/Harvard Cancer Center, providing patients with access to the latest therapies.
New Appointment Phone:
Adult Leukemia: 617-632-6028
Lymphoma: 617-632-6246
Multiple Myeloma: 617-632-3823
Stem Cell Transplantation: 617-632-3245
Waldenström's Macroglobulinemia: 617-632-3823
Fax (all programs): 617-632-3730
Leadership – Center for Hematologic Oncology
Robert J. Soiffer, MD, Chief, Division of Hematologic Malignancies and Co-Chief, Stem Cell Transplantation
Richard M. Stone, MD, Program Director, Adult Leukemia
Daniel J. DeAngelo, MD, PhD, Director of Clinical and Translational Research, Adult Leukemia
Martha Wadleigh, MD, Clinical Director, Adult Leukemia
Margaret A. Shipp, MD, Chief, Division of Hematologic Neoplasia and Program Director, Lymphoma
Eric D. Jacobsen, MD, Clinical Director, Lymphoma
Jennifer R. Brown, MD, PhD, Director, Chronic Lymphocytic Leukemia Center
Kenneth C. Anderson, MD, Program Director, Multiple Myeloma
Paul G. Richardson, MD, Clinical Program Leader and Director of Clinical Research, Multiple Myeloma
Nikhil C. Munshi, MD, Director of Basic and Correlative Science, Multiple Myeloma
Jacob Laubach, MD, MPP, Clinical Director, Multiple Myeloma
Joseph H. Antin, MD, Chief, Stem Cell Transplantation
Edwin P. Alyea, III, MD, Associate Director, Stem Cell Transplantation
Vincent T. Ho, MD, Clinical Director, Stem Cell Transplantation
Steven P. Treon, MD, PhD, Director, Waldenström's Macroglobulinemia
Treatment Team
Infectious Disease
Lindsey Robert Baden, MD
Sarah Page Hammond, MD
Nicolas C. Issa, MD
Sophia Koo, MD
Francisco Marty, MD
Medical Oncology
Gregory A. Abel, MD, MPH
Edwin P. Alyea, III, MD
Kenneth C. Anderson, MD
Joseph H. Antin, MD
Philippe Armand, MD, PhD
Bradley Blaser, MD, PhD
James E. Bradner, MD
Jennifer R. Brown, MD, PhD
George P. Canellos, MD
Jorge J. Castillo, MD
Corey S. Cutler, MD, MPH, FRCPC
Matthew S. Davids, MD
Daniel J. DeAngelo, MD, PhD
James A. DeCaprio, MD
David C. Fisher, MD
David A. Frank, MD, PhD
To make an appointment,
Arnold S. Freedman, MD
call 877-332-4294
Irene Ghobrial, MD
Brett E. Glotzbecker, MD
James D. Griffin, MD
Vincent T. Ho, MD
Eric D. Jacobsen, MD
Caron A. Jacobson, MD
John Koreth, MD, PhD
Ann S. LaCasce, MD
Andrew A. Lane, MD, PhD
Jacob Laubach, MD, MPP
Anthony G. Letai, MD, PhD
R. Coleman Lindsley, MD, PhD
Jens G. Lohr, MD, PhD
Ann Mullally, MD
Nikhil C. Munshi, MD
Lee M. Nadler, MD
Sarah Nikiforow, MD, PhD
Oreofe O. Odejide, MD
Claudia Paba-Prada, MD
Paul G. Richardson, MD
Jerome Ritz, MD
Robert L. Schlossman, MD
Margaret A. Shipp, MD
Robert J. Soiffer, MD
David P. Steensma, MD
Richard M. Stone, MD
Steven P. Treon, MD, PhD
Martha Wadleigh, MD
David M. Weinstock, MD
Catherine J. Wu, MD
Rushdia Yusuf, MD
Pathology
Jon C. Aster, MD, PhD
Ruben Carrasco, MD
David M. Dorfman, MD, PhD
Michael J. Kluk, MD, PhD
Frank C. Kuo, MD, PhD
Scott B. Lovitch, MD, PhD
Geraldine S. Pinkus, MD
Olga Pozdnyakova, MD, PhD
Scott J. Rodig, MD, PhD
Radiation Oncology
Peter M. Mauch, MD
Andrea K. Ng, MD, MPH
Imaging
www.dana-farber.org
Donald N.
Di Salvo, MD
Angela A. Giardino, MD
Heather Jacene, MD
6
Heather Jacene, MD
Christopher G. Sakellis, MD
Annick D. Van den Abbeele, MD
Hematologic Oncology - Medical Oncology
Arnold S. Freedman, MD
Academic Title: Professor of Medicine, Harvard Medical
School
Discipline: Medical Oncologist
Phone: 617-582-9086
Fax: 617-582-9086
E-mail: [email protected]
Fellowship: Dana-Farber Cancer Institute,
Hematology & Oncology
Board Certifications: Internal Medicine
Medical Oncology
Areas of Expertise: Stem cell/bone marrow transplantation,
Chronic lymphocytic leukemia,
Lymphoma, Hodgkin disease
Medical School: University of Massachusetts Medical
School
Residency: Memorial Hospital, Worcester, Internal
Medicine
To make an appointment,
call 877-332-4294
www.dana-farber.org
7